AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
This Quarter Return
+6.59%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$532M
AUM Growth
+$532M
(+0.64%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-5.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
164
New
10
Increased
32
Reduced
116
Closed
6
Top Buys
| 1 |
SharkNinja
SN
|
$8.89M |
| 2 |
Clarivate
CLVT
|
$7.84M |
| 3 |
Fox Factory Holding Corp
FOXF
|
$7.25M |
| 4 |
HealthEquity
HQY
|
$5.69M |
| 5 |
GMS Inc
GMS
|
$4.51M |
Top Sells
| 1 |
HubSpot
HUBS
|
$5.85M |
| 2 |
FirstCash
FCFS
|
$4.99M |
| 3 |
RXO
RXO
|
$4.7M |
| 4 |
PRMW
Primo Water Corporation
PRMW
|
$4.39M |
| 5 |
WillScot Mobile Mini Holdings
WSC
|
$4.38M |
Sector Composition
| 1 | Industrials | 33.01% |
| 2 | Technology | 18.8% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Financials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
APi Group
APG
$14.4B
| $3.08M | 0.58% |
+78,363
| New | +$3.08M |
|
77
Certara
CERT
$1.69B
| $2.94M | 0.55% |
164,629
+3,028
| +2% | +$54.1K |
|
78
Core & Main
CNM
$12.2B
| $2.79M | 0.53% |
48,798
-42,726
| -47% | -$2.45M |
|
79
Procore
PCOR
$10.3B
| $2.75M | 0.52% |
33,473
-3,100
| -8% | -$255K |
|
80
National Vision
EYE
$1.8B
| $2.73M | 0.51% |
123,060
-108,589
| -47% | -$2.41M |
|
81
Helios Technologies
HLIO
$1.75B
| $2.63M | 0.49% |
58,840
+16,890
| +40% | +$755K |
|
82
Guidewire Software
GWRE
$18.5B
| $2.57M | 0.48% |
22,055
-27,968
| -56% | -$3.26M |
|
83
Magnite
MGNI
$3.49B
| $2.55M | 0.48% |
237,217
-268,438
| -53% | -$2.89M |
|
84
Albany International
AIN
$1.79B
| $2.52M | 0.47% |
26,956
-27,278
| -50% | -$2.55M |
|
85
Eventbrite
EB
$262M
| $2.52M | 0.47% |
459,754
-120,718
| -21% | -$662K |
|
86
Paymentus
PAY
$4.76B
| $2.44M | 0.46% |
107,288
-38,276
| -26% | -$871K |
|
87
Agilon Health
AGL
$497M
| $2.31M | 0.43% |
378,589
-33,799
| -8% | -$206K |
|
88
Leslie's
LESL
$60.9M
| $2.22M | 0.42% |
342,256
+50,479
| +17% | +$328K |
|
89
Vericel Corp
VCEL
$1.69B
| $1.3M | 0.24% |
24,988
-8,888
| -26% | -$462K |
|
90
Entrada Therapeutics
TRDA
$202M
| $1.29M | 0.24% |
91,116
-14,021
| -13% | -$199K |
|
91
ADMA Biologics
ADMA
$4.03B
| $1.22M | 0.23% |
+184,466
| New | +$1.22M |
|
92
Ironwood Pharmaceuticals
IRWD
$201M
| $1.14M | 0.21% |
130,966
+5,261
| +4% | +$45.8K |
|
93
Voyager Therapeutics
VYGR
$204M
| $1.14M | 0.21% |
122,311
-54,560
| -31% | -$508K |
|
94
Organogenesis Holdings
ORGO
$629M
| $1.12M | 0.21% |
+396,116
| New | +$1.12M |
|
95
Veracyte
VCYT
$2.41B
| $1.12M | 0.21% |
50,534
+4,409
| +10% | +$97.7K |
|
96
Halozyme
HALO
$8.75B
| $1.1M | 0.21% |
27,079
-2,838
| -9% | -$115K |
|
97
Dynavax Technologies
DVAX
$1.19B
| $1.1M | 0.21% |
88,683
-404
| -0.5% | -$5.01K |
|
98
MiMedx Group
MDXG
$1.05B
| $1.08M | 0.2% |
139,893
-17,812
| -11% | -$138K |
|
99
Arcellx
ACLX
$3.95B
| $1.08M | 0.2% |
15,475
-7,198
| -32% | -$501K |
|
100
Alkermes
ALKS
$4.95B
| $1.06M | 0.2% |
39,008
-10,522
| -21% | -$285K |
|